Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Aitia uses its causal AI platform, the REFS engine, to build Gemini Digital Twins, which are in silico models of human disease biology. These models help biopharma partners discover, develop, and test precisely targeted drugs for diseases such as oncology and neurodegeneration.
Parse Score
Sources
marketsandmarkets.com shapes more of what AI says about Aitia than any other source, at 100% of its citations.